top of page

Executive Management

Ethan Shen, PhD

Chairman & CEO

Dr. Ethan Shen is an accomplished entrepreneur and academic leader committed to advancing global healthcare through scientific innovation and operational excellence. With more than two decades of experience across biotechnology, translational medicine, and leadership, Dr. Shen has built a distinguished reputation in the field.

“At Yong Ding Biopharm, we believe in the potential of science to shape a healthier future. Together, we aim to advance healthcare innovation and deliver meaningful solutions to those with the greatest needs.”

Benjamin Zhang, MD

Chief Medical Officer (CMO)

Dr. Benjamin Zhang is a physician-scientist and translational medicine leader dedicated to advancing next-generation therapies from bench to bedside. As Chief Medical Officer of Yong Ding Biopharm, he drives the company’s clinical and regulatory strategy, ensuring that innovations in cancer diagnostics, immunotherapy, and regenerative medicine are developed with scientific rigor and delivered with patient impact. His expertise spans IND preparation, cell and exosome therapy development, and global clinical trial execution, with a career rooted in bridging academic research and industry application. At Yong Ding Biopharm, Dr. Zhang is focused on shaping a robust medical pipeline that addresses urgent unmet needs and positions the company at the forefront of biotech innovation.

“At Yong Ding Biopharm, my mission is to translate scientific excellence into real-world treatments—bringing hope, access, and better outcomes to patients worldwide.”

Mr. Edmund Hen

Chief Financial Officer (CFO)

Mr. Edmund Hen is a seasoned financial executive with over two decades of experience in corporate finance, capital markets, and business strategy. As Chief Financial Officer (CFO) at Yong Ding Biopharm, he brings extensive expertise in financial management, regulatory compliance, and strategic business development. His leadership has been pivotal in supporting the company’s growth and expansion initiatives.

“At Yong Ding Biopharm, we recognize that sound financial stewardship is essential for driving sustainable growth. Through collaboration, innovation, and disciplined financial strategy, we are committed to advancing our mission and delivering long-term value to patients and stakeholders.”

bottom of page